Safety and Efficacy of AIN457 in Noninfectious Uveitis

Completed · Phase 2

Conditions studied: Non-infectious Uveitis

In brief

This study was performed to evaluate the efficacy and safety of AIN457 for patients with active uveitis that requires systemic immunosuppression.

Key facts

Study ID

NCT00685399

Run by

Novartis Pharmaceuticals

People needed

76

Starts

2008-06-01

Expected to finish

2013-09-01

Last updated by the study team

2017-07-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Active uveitis (i.e., uveitis that is not in remission).
• Intermediate uveitis, posterior uveitis, or panuveitis must be sufficiently severe that systemic immunosuppression is indicated.

You may not qualify if…

• Active infection.
• Weight must not be greater that 120kg.
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Novartis Investigative Site — Beverly Hills, California, United States
• Novartis Investigative Site — Los Angeles, California, United States
• Novartis Investigative Site — Sacramento, California, United States
• Novartis Investigative Site — Denver, Colorado, United States
• Novartis Investigative Site — Golden, Colorado, United States
• Novartis Investigative Site — Littleton, Colorado, United States
• Novartis Investigative Site — Atlanta, Georgia, United States
• Novartis Investigative Site — Baltimore, Maryland, United States
• Novartis Investigative Site — Baltimore, Maryland, United States
• Novartis Investigative Site — Cambridge, Massachusetts, United States
• Novartis Investigative Site — Kansas City, Missouri, United States
• Novartis Investigative Site — Teaneck, New Jersey, United States
• Novartis Investigative Site — New York, New York, United States
• Novartis Investigative Site — Slingerlands, New York, United States
• Novartis Investigative Site — Durham, North Carolina, United States
• Novartis Investigative Site — Cleveland, Ohio, United States
• Novartis Investigative Site — Spartanburg, South Carolina, United States
• Novartis Investigative Site — Arlington, Texas, United States
• Novartis Investigative Site — Austin, Texas, United States
• Novartis Investigative Site — Houston, Texas, United States
• Novartis Investigative Site — Berlin, Germany
• Novartis Investigative Site — Heidelberg, Germany
• Novartis Investigative Site — Tübingen, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.